Literature DB >> 2866963

Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.

M Tangø, J E Carlsen, J Trap-Jensen.   

Abstract

Dose-response curves for heart rate, arterial blood pressure, cardiac output, total peripheral resistance, systolic time intervals, forearm blood flow and forearm vascular resistance were obtained after i.v. administration of seven logarithmically increasing doses of xamoterol to 8 healthy volunteers. The total cumulative dose was 0.2 mg/kg b.w. At rest after the seventh dose of xamoterol heart rate, systolic blood, pressure, cardiac output and forearm blood flow were increased by 10%, 20%, 23% and 41%, respectively. Diastolic blood pressure was unchanged. Forearm vascular resistance was reduced by 21% and total peripheral resistance by 10%. Systolic time intervals were reduced: total electromechanical systole index (QS2I), left ventricular ejection time index (LVETI), pre ejection period index (PEPI) and PEP/LVET ratio by 4%, 2%, 12% and 14%, respectively. No side-effects were observed. During upright exercise after the seventh dose of xamoterol heart rate was reduced by 11% and systolic BP by 6%. Diastolic blood pressure was unchanged. Thus xamoterol increased the contractility of the heart with only a small increase in heart rate, increased systolic blood pressure and caused vasodilatation in resting skeletal muscle. During exercise the reduction in heart rate and blood pressure suggests beta-adrenoceptor blocking activity of the drug.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866963     DOI: 10.1007/bf00547414

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Cardiovascular effects of isoproterenol in normal subjects and subjects with congestive heart failure.

Authors:  H T DODGE; J D LORD; H SANDLER
Journal:  Am Heart J       Date:  1960-07       Impact factor: 4.749

Review 2.  Dobutamine: a new synthetic cardioactive sympathetic amine.

Authors:  E H Sonnenblick; W H Frishman; T H LeJemtel
Journal:  N Engl J Med       Date:  1979-01-04       Impact factor: 91.245

3.  The Minnesota impedance cardiograph- theory and applications.

Authors:  W G Kubicek; J Kottke; M U Ramos; R P Patterson; D A Witsoe; J W Labree; W Remole; T E Layman; H Schoening; J T Garamela
Journal:  Biomed Eng       Date:  1974-09

4.  A strain gauge plethysmograph with electrical calibration.

Authors:  T Hallböök; B Månsson; R Nilsén
Journal:  Scand J Clin Lab Invest       Date:  1970-06       Impact factor: 1.713

5.  Bedside technics for the evaluation of ventricular function in man.

Authors:  A M Weissler; W S Harris; C D Schoenfeld
Journal:  Am J Cardiol       Date:  1969-04       Impact factor: 2.778

6.  Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587.

Authors:  H Pouleur; M F Rousseau; P Mengeot; C Veriter; M F Vincent; L A Brasseur
Journal:  Eur Heart J       Date:  1982-12       Impact factor: 29.983

7.  The cardiovascular acitivity of ICI 118,587 a novel beta-adrenoceptor partial agonist [proceedings].

Authors:  J J Barlow; B D Main; J A Moors; A Nuttall; H M Snow
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

8.  The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.

Authors:  A Nuttall; H M Snow
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

9.  Beta-adrenoceptor stimulant properties of amidoalkylamino-substituted 1-aryl-2-ethanols and 1-(aryloxy)-2-propanols.

Authors:  J J Barlow; B G Main; H M Snow
Journal:  J Med Chem       Date:  1981-03       Impact factor: 7.446

10.  Immediate haemodynamic effects of prenalterol, a new adrenergic beta-1-receptor agonist, in healthy volunteers.

Authors:  T L Svendsen; O J Hartling; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

View more
  5 in total

Review 1.  Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Authors:  D G Waller
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

Review 2.  Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  R Furlong; R N Brogden
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

Review 3.  Clinical pharmacology of epanolol. Pharmacodynamic aspects.

Authors:  J D Harry
Journal:  Drugs       Date:  1989       Impact factor: 9.546

4.  Differential effects of beta-adrenoceptor partial agonists in patients with postural hypotension.

Authors:  J Mehlsen; C Stadeager; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Lack of pharmacodynamic interactions between acute dose flosequinan and xamoterol. A pilot study in healthy subjects.

Authors:  H W Ng; T J Walley; Y Tsao; A M Breckenridge
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.